Hypomethylating agent (HMA) treatment as a bridge to allogeneic hematopoietic cell transplantation (HCT) for relapsed/refractory acute myeloid leukemia (RR-AML).

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. 7033-7033 ◽  
Author(s):  
Michael Richard Grunwald ◽  
Danielle Boselli ◽  
Lauren M. Bohannon ◽  
Michael Keith Alister Zimmerman ◽  
Jing Ai ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document